Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lidocaine spray may replace fentanyl for tube insertion stress

NCT ID NCT07533643

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested if a lidocaine spray and mouth rinse before surgery could reduce stress from inserting a breathing tube, compared to a standard IV painkiller (fentanyl). 50 adults having elective surgery participated. The goal was to see which method better controlled blood pressure changes right after tube placement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Aug 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * American society of anaesthesiologists class 1 or 2 (ASA 1 or 2) patients. * Patients undergoing elective surgeries under general anaesthesia with endotracheal intubation using direct laryngoscope. * Population aged from 18 to 60 years. Exclusion Criteria: * Patient's refusal to participate. * ASA class 3 or more patients including Substantive functional limitations; One or more moderate to severe diseases. Poorly controlled DM or HTN, COPD, morbid obesity (BMI ≥40), active hepatitis, alcohol dependence or abuse, implanted pacemaker, reduction of ejection fraction, ESRD undergoing regularly scheduled dialysis, history of MI, CVA, TIA, or CAD/stents, asthma with exacerbation, poorly controlled epilepsy. * Patients with any degree of Hypertension or treated for hypertension. * Pregnant patients. * Age of participant less than 18 or more than 60 years. * History of allergy to local anaesthetics or opioids. * Opioid abuse * Anticipated difficult airway which will be defined as El-Ganzouri Risk Index (EGRI) score of 4 or more points. * Difficult intubation which will be defined as situation where proper insertion of the tracheal tube with conventional laryngoscopy requires more than three attempts or more than 10 min. * Difficult mask ventilation which will be defined as a situation that develops when it is not possible for the unassisted anaesthesiologist to maintain the oxygen saturation \>90% using 100% oxygen and positive pressure ventilation, or to prevent or reverse signs of inadequate ventilation. * Patients requiring more than one attempt of intubation. * Intubation time more than 30 seconds. * Emergency surgeries or patients requiring rapid sequence induction for other reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemodynamics after endotracheal intubation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kasr Alainy Medical School

    Cairo, Egypt